1. Travere Therapeutics Inc
  2. Travere Therapeutics Inc Ownership

Historical shareholding details of Emerald Mutual Fund Advisers Trust holdings in Travere Therapeutics Inc (TVTX)

Monthly changes of Emerald Mutual Fund Advisers Trust shareholding in Travere Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Emerald Mutual Fund Advisers Trust 494,279 0.56%
Feb 28, 2025 Emerald Mutual Fund Advisers Trust 494,279 0.56%
Jan 31, 2025 Emerald Mutual Fund Advisers Trust 494,279 0.57%
Dec 31, 2024 Emerald Mutual Fund Advisers Trust 1,101,774 1.24%
Dec 31, 2024 Emerald Mutual Fund Advisers Trust 494,279 0.57%
Nov 30, 2024 Emerald Mutual Fund Advisers Trust 494,279 0.57%
Oct 31, 2024 Emerald Mutual Fund Advisers Trust 541,723 0.69%
Sep 30, 2024 Emerald Mutual Fund Advisers Trust 1,185,709 1.36%
Sep 30, 2024 Emerald Mutual Fund Advisers Trust 541,723 0.71%
Aug 31, 2024 Emerald Mutual Fund Advisers Trust 340,733 0.45%
Jul 31, 2024 Emerald Mutual Fund Advisers Trust 342,842 0.45%
Jun 30, 2024 Emerald Mutual Fund Advisers Trust 941,265 1.23%
Jun 30, 2024 Emerald Mutual Fund Advisers Trust 342,842 0.45%
May 31, 2024 Emerald Mutual Fund Advisers Trust 342,842 0.45%
Apr 30, 2024 Emerald Mutual Fund Advisers Trust 698,168 0.92%
Mar 31, 2024 Emerald Mutual Fund Advisers Trust 1,328,381 1.74%
Mar 31, 2024 Emerald Mutual Fund Advisers Trust 698,168 0.92%
Feb 29, 2024 Emerald Mutual Fund Advisers Trust 336,709 0.44%
Jan 31, 2024 Emerald Mutual Fund Advisers Trust 336,709 0.45%
Dec 31, 2023 Emerald Mutual Fund Advisers Trust 764,603 1.00%
Dec 31, 2023 Emerald Mutual Fund Advisers Trust 336,709 0.45%
Nov 30, 2023 Emerald Mutual Fund Advisers Trust 336,709 0.45%
Oct 31, 2023 Emerald Mutual Fund Advisers Trust 336,709 0.45%
Sep 30, 2023 Emerald Mutual Fund Advisers Trust 764,603 1.02%
Sep 30, 2023 Emerald Mutual Fund Advisers Trust 336,709 0.45%
Aug 31, 2023 Emerald Mutual Fund Advisers Trust 283,471 0.38%
Jun 30, 2023 Emerald Mutual Fund Advisers Trust 529,518 0.71%

View all ownership details of Travere Therapeutics Inc